Everything you care about in one place

Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.

Get Feeder

google.co.in

Google Alert - dupilumab

Get the latest updates from Google Alert - dupilumab directly as they happen.

Follow now 112 followers

Latest posts

Last updated about 2 hours ago

Atopic dermatitis associated with systemic tacrolimus: Case report and review

about 6 hours ago

... dupilumab. After 1 month, her skin had considerably improved and further...

Dupilumab relieves pruritus both in uremic pruritus and in atopic dermatitis with chronic ...

about 15 hours ago

Exploring the therapeutic potential of dupilumab in alleviating pruritus in CKD patients...

FeNO-Messung nur zur Indikationsstellung einer Dupilumab-Therapie - KBV

about 17 hours ago

Dupilumab wird als Add-on-Erhaltungstherapie bei Erwachsenen und Jugendlichen ab zwölf Jahren mit...

Biomarker-Associated Remission After Switching to Dupilumab in Severe Asthma Following ... - MDPI

about 21 hours ago

... dupilumab. Methods: We reviewed data from the Allergy and Clinical Immunology...

Dupilumab治疗对慢性鼻窦炎伴鼻息肉患者3D鼻球状体上皮组织的修复作用 - 生物通

about 22 hours ago

研究对比了未治疗组、Dupilumab治疗16周组及下鼻甲肥大对照组的球状体形成能力,发现治疗组能形成结构完整的球状体并伴随边缘运动,提示该生物制剂可能通过调节2型 ...

Sanofi's Dupilumab Study: A Potential Game-Changer for Chronic Pruritus - MSN

1 day ago

Sanofi's Dupilumab Study: A Potential Game-Changer for Chronic Pruritus. Story by TipRanks...

Dupixent Lawsuit | Get Free Case Evaluation

1 day ago

Dupixent (dupilumab) side effects include cutaneous T-cell lymphoma (CTCL), other serious T-cell...

度普利尤单抗治疗特应性皮炎对皮肤神经解剖结构及细胞应答的调控机制研究 - 生物通

1 day ago

编辑推荐:. 本研究针对特应性皮炎(AD)患者瘙痒机制不明的问题,通过分析49例重度AD患者接受度普利尤单抗(dupilumab)治疗16周前后的皮肤神经纤维密度(IENFD)、 ...

Dermatite atopica, lebrikizumab efficace a 16 settimane anche nella real life - Pharmastar

1 day ago

... dupilumab 17 mesi, range 4-56); i pazienti che avevano precedentemente fallito...

The Role of Immunotherapy in Managing Nasal Polyps: Insights for Allergists and ENTs

1 day ago

Currently, there are four biologics approved to treat CRSwNP. They include: dupilumab...

How to Individualize Biologic Therapy in Severe Prurigo Nodularis - Dermatology Times

1 day ago

Although both dupilumab and nemolizumab are effective for PN, dupilumab was selected...

Allergy EAACI on X: "Open Access: Efficacy of Omalizumab, Dupilumab, and Remibrutinib in ...

1 day ago

Open Access: Efficacy of Omalizumab, Dupilumab, and Remibrutinib in Chronic Spontaneous Urticaria...